8-K
filed June 5, 2026, 4:00 PM ET
ticker ASMB
CIK 0001426800
other material
confidence high
sentiment neutral
materiality 0.45
Assembly Biosciences shareholders approve equity plan share increases; all director nominees elected
ASSEMBLY BIOSCIENCES, INC.
- Amendment No. 3 to 2018 Stock Incentive Plan approved; shares reserved increased from 1,478,333 to 2,678,333 (increase of 1,200,000).
- Amendment No. 2 to Employee Stock Purchase Plan approved; shares reserved increased from 225,000 to 515,000 (increase of 290,000).
- All nine director nominees elected: Altig, Cihlar, Consylman, Cook II, Houghton, Johnson-Pratt, Mahony, McHutchison, Okazaki.
- Advisory say-on-pay approved (11,293,061 for, 5,401 against); ratification of Ernst & Young as auditor approved.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
ASSEMBLY BIOSCIENCES, INC. shareholders approved Election of nine directors to serve until the 2027 annual meeting at the 2026-06-04 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2026-06-04
Exact text from the filing
The stockholders elected of the following to serve on the Company's Board of Directors until the Company's 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Anthony E. Altig; Tomas Cihlar, Ph.D.; Gina Consylman; Robert D. Cook II; Sir Michael Houghton, Ph.D.; Lisa R. Johnson-Pratt, M.D.; Susan Mahony, Ph.D.; John G. McHutchison, A.O., M.D.; and Jason A. Okazaki.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
ASSEMBLY BIOSCIENCES, INC. shareholders approved Ratification of Ernst & Young LLP as independent auditor for fiscal year 2026 at the 2026-06-04 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2026-06-04
Exact text from the filing
The stockholders ratified the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
ASSEMBLY BIOSCIENCES, INC. shareholders approved Approval of Amendment No. 3 to 2018 Plan to increase shares reserved by 1,200,000 at the 2026-06-04 meeting.
- Proposal
- equity plan
- Outcome
- passed
- Meeting
- 2026-06-04
Exact text from the filing
The stockholders approved Amendment No. 3 to the 2018 Plan to increase the number of shares reserved for issuance under the 2018 Plan by 1,200,000 shares.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
ASSEMBLY BIOSCIENCES, INC. shareholders approved Approval of ESPP Amendment No. 2 to increase shares reserved to 515,000 at the 2026-06-04 meeting.
- Outcome
- passed
- Meeting
- 2026-06-04
Exact text from the filing
The stockholders approved the ESPP Amendment No. 2 to increase the number of shares reserved under the ESPP to 515,000 shares.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
ASSEMBLY BIOSCIENCES, INC. shareholders approved Advisory vote on named executive officers' compensation at the 2026-06-04 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2026-06-04
Exact text from the filing
The stockholders approved, on a non-binding advisory basis, the Company's named executive officers' compensation disclosed in the Proxy Statement.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.